Marie-Christine Chartier-Harlin

Association between Parkinson's disease and polymorphisms in the nNOS and iNOS genes in a community-based case-control study.

S18Y polymorphism in the UCH-L1 gene and Parkinson's disease: evidence for an age-dependent relationship.

CYP2D6 polymorphism, pesticide exposure, and Parkinson's disease.

UCHL1 is a Parkinson's disease susceptibility gene.

Interleukin-6 promoter polymorphism: risk and pathology of Alzheimer's disease.

Alpha-synuclein locus duplication as a cause of familial Parkinson's disease.

Association study and meta-analysis of low-density lipoprotein receptor related protein in Alzheimer's disease.

Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease.

Prenatal stress has pro-inflammatory consequences on the immune system in adult rats.

Genomic investigation of alpha-synuclein multiplication and parkinsonism.

Transcriptional profile of Parkinson blood mononuclear cells with LRRK2 mutation.

Independent and joint effects of the MAPT and SNCA genes in Parkinson disease.

SNCA locus duplication carriers: from genetics to Parkinson disease phenotypes.

Role of sepiapterin reductase gene at the PARK3 locus in Parkinson's disease.

Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study.

Translation initiator EIF4G1 mutations in familial Parkinson disease.

Population-specific frequencies for LRRK2 susceptibility variants in the Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium.

Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants.

Involvement of the immune system, endocytosis and EIF2 signaling in both genetically determined and sporadic forms of Parkinson's disease.

Alpha-synuclein repeat variants and survival in Parkinson's disease.

Deregulation of protein translation control, a potential game-changing hypothesis for Parkinson's disease pathogenesis.